Business and Finance

Expansion expected to help tackle health issues at a faster rate, company says

Annual report finds continuing impact of COVID-19 on global markets

Partnership aims to lower prescription drug costs and increase price transparency

Dr. Liz Kwo of Everly Health outlines 2023 predictions for AI, including how it can be beneficial to patients

Provider’s regulatory affairs, pharmacovigilance services expected to help increase ABC’s portfolio

A Q&A with AstraZeneca’s Country President for Belgium & Luxembourg, Keira Driansky

Dr. Troy Sarich of Janssen reveals the company's approach to tackling financial challenges as they pertain to tech

Purchase strengthens Amgen’s therapeutics portfolio

Drug safety analysis to be conducted at Rockland, MD facility

A Harvard Business School Healthcare Alumni Association C-suite Q&A with Mark Cuban, Cost Plus Drugs co-founder

With purchase, UPS Healthcare can grow coverage in Europe, LATAM

Agreement revolves around sustainability, but also features implementation of new bioprocess development methods

Purchase will help CDMO expand into European market

Kaysersberg facility’s Lab+ deal expected to bolster CDMO’s filling services

Non-exclusive deal intends to popularize RTU containment solutions within pharma industry

Deal is valued at $21.9 million

Invests $5 million to upgrade manufacturing processes

Healthcare marketing agency acquisition augments company’s commercialization portfolio

Agreement featuring UK pharma services consultancy intends to grow PharmaLex's pan-European market access presence

HCP-driven partnership calls for greater engagement across the life science sector

Distributor is able to reach more patients as a result  

With deal, drug wholesaler grows its biopharma services platform

With integrated supply chain platform, strategic partnership looks to accelerate cell therapy program development

Collaboration will be powered by tech company’s AI services

Acquisition helps grow its CDMO capabilities

Professor Laura Empson pulls back the curtain on insecure overachieving professionals and explains how they can come to accept damaging patterns of overwork as inevitable and even desirable

Financial commitment expected to benefit capabilities of single-use assemblies

Allows CDMO’s regulatory, consulting services to further expand into the pharma market

Among goals, product aims to mitigate supply chain risk for pharma and biotech industries

Location expands company’s pharmacovigilance, regulatory affairs services